Sinclair Pharma PLC Company Profile (LON:SPH)

Analyst Ratings

Consensus Ratings for Sinclair Pharma PLC (LON:SPH) (?)
Ratings Breakdown: 1 Hold Rating(s), 4 Buy Rating(s)
Consensus Rating:Buy (Score: 2.80)
Consensus Price Target: GBX 53

Analysts' Ratings History for Sinclair Pharma PLC (LON:SPH)
Show:
DateFirmActionRatingPrice TargetActions
7/19/2016Stifel NicolausReiterated RatingBuyGBX 49View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/19/2016Peel HuntReiterated RatingBuyGBX 66View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/15/2016Jefferies GroupLower Price TargetBuyGBX 60 -> GBX 55View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2016N+1 SingerLower Price TargetBuyGBX 52 -> GBX 42View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/28/2015Panmure GordonReiterated RatingUnder ReviewView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/28/2015InvestecDowngradeHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015FinnCapDowngradeHoldGBX 43View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/27/2015Canaccord GenuityReiterated RatingBuyGBX 44View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Oriel Securities LtdReiterated RatingAddGBX 40View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/17/2015Shore CapitalReiterated RatingHoldView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 7/25/2014 forward)

Earnings

Earnings History for Sinclair Pharma PLC (LON:SPH)
No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Earnings Estimates for Sinclair Pharma PLC (LON:SPH)
No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for Sinclair Pharma PLC (LON:SPH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Sinclair Pharma PLC (LON:SPH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/27/2016Tschudin,Jean-CharlesInsiderBuy97,000GBX 36£34,920Tweet This Trade  Share This Trade on StockTwits
5/26/2016Tschudin,Jean-CharlesInsiderBuy3,023GBX 35£1,058.05Tweet This Trade  Share This Trade on StockTwits
5/23/2016Olby,AlanInsiderBuy50,000GBX 35£17,500Tweet This Trade  Share This Trade on StockTwits
5/20/2016Foucher,ChristopheInsiderBuy31,500GBX 35£11,025Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Sinclair Pharma PLC (LON:SPH)
DateHeadline
07/19/16 06:43 PMTrading update and notification of board changes £17.2m revenue in 1H calendar 2016
07/19/16 06:43 PMSinclair Pharma H1 Revenues Surge; Affirms 2016 Outlook - Quick Facts
07/19/16 06:43 PMSinclair IS Pharma PLC (LON:SPH) target price maintained at 66GBX as disclosed today by Peel Hunt
07/07/16 06:31 AMSinclair CEO Chris Spooner on Modern Aesthetics TV - [at noodls] - Chris Spooner talks with Steven Dayan, MD, FACS about bringing Silhouette InstaLift to the US. InstaLift differs from other generations of sutures because it's resorbable and has cones that hook the subdermal ...
06/16/16 10:55 AMSinclair IS Pharma PLC (LON:SPH) stock price target reduced to GBX55 as issued in a report today by Jefferies International
06/08/16 12:46 PMSinclair Pharma Plc – Value Analysis (LONDON:SPH) : June 8, 2016 -
06/07/16 03:35 AMSinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : SPH-GB : June 7, 2016 -
06/03/16 05:15 AMSinclair Pharma to Present at the Jefferies 2016 Healthcare Conference on 7th June - [at noodls] - London, 2 June 2016 Sinclair Pharma plc (SPH.L), ('Sinclair' or the 'Company') the international aesthetics company, today announces that Chris Spooner, Sinclair's Chief Executive Officer, will present ...
06/01/16 07:10 PMSinclair Pharma : Director Dealing - 31 May 2016,Sinclair Pharma plc (SPH.L) ('Sinclair' or the 'Company') the international aesthetics company, was advised on 27 May, that on that day Jean-Charles Tschudin, Non-Executive Director, acquired 97,000 ordinary shares of 1p each ('Ordinary Shares ...
06/01/16 11:55 AMSinclair Pharma plc Agrees Major Amendment to AQTIS Acquisition Contract - [at noodls] - Immediate one off payment significantly reduces deferred consideration London, 30 March 2016 Sinclair Pharma plc (SPH.L), ('Sinclair' or the 'Company') the international specialty pharma company, today ...
05/25/16 01:59 PMSinclair Pharma PLC 86.8% Potential Upside Indicated by Peel Hunt - DirectorsTalk Interviews - Sinclair Pharma PLC 86.8% Potential Upside Indicated by Peel HuntDirectorsTalk InterviewsSinclair Pharma PLC with EPIC/TICKER LON:SPH has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Peel Hunt. Sinclair Pharma PLC are listed in the Health Care sector within AIM. Peel Hunt have ...and more »
05/24/16 04:36 AMPurchase of shares by Chief Financial Officer - [at noodls] - Sinclair Pharma plc 24 May 2016,Sinclair Pharma plc (SPH.L) ('Sinclair' or the 'Company') the international aesthetics company, was advised on 23 May, that on that day Alan Olby, Chief Financial Officer, ...
05/23/16 12:18 PMDirector dealings: Jardine Matheson's Keswick sells shares -
05/23/16 03:36 AMSinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : SPH-GB : May 23, 2016 -
05/21/16 01:43 PMFTSE up as beverages, resources and financials fly - Stock Market Wire - FTSE up as beverages, resources and financials flyStock Market WireStockMarketWire.com - London equities sped away from yesterday's sea of red that swamped global stocks, metals and crude-oil pricing, with traders sniffing out value buys as markets came to terms with a potential US rate rise in June and increasingly ...
05/21/16 01:43 PMSinclair Pharma PLC 77.8% Potential Upside Indicated by Jefferies International - DirectorsTalk Interviews - Sinclair Pharma PLC 77.8% Potential Upside Indicated by Jefferies InternationalDirectorsTalk InterviewsSinclair Pharma PLC using EPIC/TICKER code LON:SPH has had its stock rating noted as 'Reiterates' with the recommendation being set at 'BUY' today by analysts at Jefferies International. Sinclair Pharma PLC are listed in the Health Care sector within AIM.and more »
05/20/16 05:20 AMDon’t buy or sell Sinclair Pharma plc, Ladbrokes plc or Close Brothers Group plc until you’ve read this! -
05/19/16 01:44 PMGoodbye, my love! - Proactive Investors USA & Canada - Goodbye, my love!Proactive Investors USA & CanadaProfits are rising nicely boosted by its buy of Sinclair Pharma (LON:SPH) and indeed I do wonder whether APH might end up as a bid target itself - there are quite a few deals going on in this sector. Whichever way I look at it it seems like a good ...and more »
05/19/16 11:42 AMUS Collaboration and Positive Trading Update - [at noodls] - · Transformational US distribution and strategic marketing agreement with Thermi for Silhouette InstaLift™ delivers immediate access through 55 sales reps to the world's largest aesthetics market o Complements ...
05/19/16 10:42 AMTransformational US Distribution Agreement - [at noodls] - Sinclair Pharma plc signs transformational US collaboration with Almirall's aesthetics subsidiary Thermi, completion of strategic review, end of offer period and provides positive trading update Transformational ...
05/19/16 10:42 AMInvestor Presentation – Transformational Agreement for Key US Market - [at noodls] - Investor Presentation – Transformational Agreement for Key US Market
05/07/16 07:45 AMWere Analysts Bullish Sinclair Pharma PLC (LON:SPH) This Week? - B.O.D.Y Confidential - Were Analysts Bullish Sinclair Pharma PLC (LON:SPH) This Week?B.O.D.Y ConfidentialOut of 3 analysts covering Sinclair IS Pharma PLC (LON:SPH), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. Sinclair IS Pharma PLC has been the topic of 5 analyst reports since August 5, 2015 according to StockzIntelligence Inc.
05/02/16 03:37 AMSinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : SPH-GB : May 2, 2016 -
04/28/16 08:25 AMHow Analysts Rated Sinclair Pharma PLC (LON:SPH) Last Week? - The Post - How Analysts Rated Sinclair Pharma PLC (LON:SPH) Last Week?The PostOut of 3 analysts covering Sinclair IS Pharma PLC (LON:SPH), 3 rate it a “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. Sinclair IS Pharma PLC has been the topic of 5 analyst reports since August 5, 2015 according to StockzIntelligence Inc.and more »
04/21/16 09:22 AMSinclair Pharma (LON:SPH) Morning Trade Volumes - Share Trading News - Share Trading NewsSinclair Pharma (LON:SPH) Morning Trade VolumesShare Trading NewsSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, ...
04/15/16 12:18 PMSinclair Pharma PLC (SPH) PT Lowered to GBX 42 at N+1 Singer - Washington News Wire - Share Trading NewsSinclair Pharma PLC (SPH) PT Lowered to GBX 42 at N+1 SingerWashington News WireSinclair Pharma PLC logo Sinclair Pharma PLC (LON:SPH) had its price objective decreased by investment analysts at N+1 Singer from GBX 52 ($0.74) to GBX 42 ($0.60) in a research report issued on Friday, AnalystRatings.NET reports. The firm presently ...N 1 Singer Reiterated Sinclair Pharma (LON:SPH) As 'Buy'Share Trading NewsSinclair Pharma reiterated as Buy By N 1 SingerRisers & Fallersall 4 news articles »
04/07/16 11:30 AMSinclair Pharma Plc :SPH-GB: Earnings Analysis: For the six months ended December 31, 2015 -
04/05/16 01:47 PMCould Sinclair Pharma PLC See a Reversal After This Very Strong Session? - Clinton Financial - FTSE NewsCould Sinclair Pharma PLC See a Reversal After This Very Strong Session?Clinton FinancialThe stock of Sinclair Pharma PLC (LON:SPH) is a huge mover today! The stock increased 2.82% or GBX 1 on April 4, hitting GBX 36.5. About 480,789 shares traded hands. Sinclair Pharma PLC (LON:SPH) has declined 5.81% since September 1, 2015 and is ...Could Sinclair Pharma PLC Change Direction After Today's Gap Up?RiversideGazette.comall 1,384 news articles »
04/02/16 12:27 PMAnalysts Consensus For Sinclair Pharma (LON:SPH) - Risers & Fallers - Share Trading NewsAnalysts Consensus For Sinclair Pharma (LON:SPH)Risers & FallersA number of investment brokers have recently updated their price targets on shares of Sinclair Pharma (LON:SPH). According to the latest ... Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company.Sinclair Pharma (LON:SPH): Executed Morning TradesShare Trading Newsall 3 news articles »
03/30/16 01:36 PMSPH amends contract, posts wider FY loss - Stock Market Wire - SPH amends contract, posts wider FY lossStock Market Wire"31% in-market growth during H1 FY16 was strong but in fact slightly below the Company's expectations due to currency related weakness in Russia and Brazil, and contractual issues with distributors in Korea." At 9:22am: [LON:SPH] Sinclair IS Pharma PLC ...and more »
03/30/16 01:36 PMShould You Buy Cap-XX Limited, Sinclair Pharma PLC And Manx Telecom PLC After Today's Results? - Motley Fool UK - Should You Buy Cap-XX Limited, Sinclair Pharma PLC And Manx Telecom PLC After Today's Results?Motley Fool UKWe also had interim results from Sinclair Pharma (LSE: SPH) today. They were greeted with a little more enthusiasm and the share price gained 3.4% to 34.6p as a result. Sinclair, which specialises in aesthetic dermatology (skin lifiting, collagen ...
03/30/16 01:36 PMSinclair Pharma (LON:SPH) Morning Share Trades - Share Trading News - Share Trading NewsSinclair Pharma (LON:SPH) Morning Share TradesShare Trading NewsAt 12:32pm on Tuesday 29th of March roughly 139,045 shares in Sinclair Pharma (LON:SPH) during the morning had been sold by investors whilst 94,833 were purchased making 40.55 percent of the shares being traded on the buy side of the market.and more »
03/30/16 07:25 AMShould You Buy Cap-XX Limited, Sinclair Pharma PLC And Manx Telecom PLC After Today’s Results? -
03/30/16 06:07 AMHalf Year 2016 Sinclair Pharma PLC Earnings Release - Before Market Open -
03/30/16 02:45 AMAmendment to AQTIS Acquisition Contract Agreed - [at noodls] - RNS Number : 4610T Sinclair Pharma PLC 30 March 2016 Sinclair Pharma plc Agrees Major Amendment to AQTIS Acquisition Contract Immediate one off payment significantly reduces deferred consideration London, ...
03/26/16 01:25 PMSinclair Pharma (LON:SPH) New Price Targets - FTSE News - Sinclair Pharma (LON:SPH) New Price TargetsFTSE NewsRecently stock market broker analysts have updated their ratings and price targets on shares of Sinclair Pharma (LON:SPH). The latest ... Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company.and more »
03/22/16 09:55 AMAnnual Report 2013: Focused on Dermatology - [at noodls] - Annual Report 2013: Focused on Dermatology
03/22/16 09:55 AMAnnual Report 2012: Delivering sustainable growth - [at noodls] - Annual Report 2012: Delivering sustainable growth
03/18/16 01:28 PMSinclair Pharma (LON:SPH) Morning Trade Activity - Share Trading News - Sinclair Pharma (LON:SPH) Morning Trade ActivityShare Trading NewsSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, ...
03/18/16 01:28 PMHow Analysts Feel About Sinclair Pharma PLC (LON:SPH)? - Stock Caller - How Analysts Feel About Sinclair Pharma PLC (LON:SPH)?Stock CallerOut of 3 analysts covering Sinclair IS Pharma PLC (LON:SPH), 3 rate it “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. Sinclair IS Pharma PLC was the topic in 5 analyst reports since August 5, 2015 according to StockzIntelligence Inc ...and more »
03/17/16 01:12 PMWhat Next for Sinclair Pharma PLC Stock After Reaching 52-Week Low? - Clinton Financial - What Next for Sinclair Pharma PLC Stock After Reaching 52-Week Low?Clinton FinancialThe stock of Sinclair Pharma PLC (LON:SPH) hit a new 52-week low and has GBX 30.48 target or 11.00% below today's GBX 34.25 share price. The 9 months bearish chart indicates high risk for the GBX 169.76 million company. The 1-year low was reported ...Analyst Coverage Updates - Sinclair Pharma (LON:SPH)Risers & FallersSinclair Pharma (LON:SPH) Morning Trade VolumesShare Trading Newsall 6 news articles »
03/12/16 12:48 PMHow Many Sinclair Pharma PLC (LON:SPH)'s Analysts Are Bearish? - Business Standard Tribune - How Many Sinclair Pharma PLC (LON:SPH)'s Analysts Are Bearish?Business Standard TribuneOut of 3 analysts covering Sinclair IS Pharma PLC (LON:SPH), 3 rate it “Buy”, 0 “Sell”, while 1 “Hold”. This means 75% are positive. Sinclair IS Pharma PLC was the topic in 5 analyst reports since August 5, 2015 according to StockzIntelligence Inc ...and more »
03/10/16 12:53 PMEnd Of Day Update On Sinclair Pharma (LON:SPH) Stock Trades - Share Trading News - End Of Day Update On Sinclair Pharma (LON:SPH) Stock TradesShare Trading NewsAt 05:50pm on Wednesday 9th of March roughly 95,729 shares in Sinclair Pharma (LON:SPH) during the day had been sold by investors whilst 53,451 were purchased making 35.83 percent of the shares being traded on the buy side of the market.
03/10/16 12:53 PMMid-Day Update On Sinclair Pharma (LON:SPH) Stock Trades - Share Trading News - Mid-Day Update On Sinclair Pharma (LON:SPH) Stock TradesShare Trading NewsSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, ...
03/03/16 01:58 PMSinclair Pharma (LON:SPH) Analyst Target Changes - Share Trading News - Sinclair Pharma (LON:SPH) Analyst Target ChangesShare Trading NewsA number of investment brokers have recently updated their price targets on shares of Sinclair Pharma (LON:SPH). According to the latest ... Sinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company.
02/26/16 07:10 AMAnalyst Coverage Updates - Sinclair Pharma (LON:SPH) - Risers & Fallers - Analyst Coverage Updates - Sinclair Pharma (LON:SPH)Risers & FallersRecently stock market analysts have updated their consensus ratings on shares of Sinclair Pharma (LON:SPH). The latest broker reports which are currently outstanding on Thursday 25th of February state 3 analysts have a rating of “strong buy”, 0 ...
02/16/16 11:47 AMSinclair Pharma PLC's Stock Is Sell After Today's Huge Decline - Sonoran Weekly Review - Sinclair Pharma PLC's Stock Is Sell After Today's Huge DeclineSonoran Weekly ReviewThe stock of Sinclair Pharma PLC (LON:SPH) is a huge mover today! The stock decreased 2.52% or GBX 1 on February 15, hitting GBX 38.75. About 54,276 shares traded hands. Sinclair Pharma PLC (LON:SPH) has declined 3.13% since July 15, 2015 and ...and more »
02/15/16 03:30 AMSinclair Pharma Plc breached its 50 day moving average in a Bullish Manner : February 15, 2016 -
02/11/16 11:31 AMRecent Broker Updates On Sinclair Pharma (LON:SPH) - Risers & Fallers - Recent Broker Updates On Sinclair Pharma (LON:SPH)Risers & FallersSinclair IS Pharma plc is a United Kingdom-based specialty pharmaceutical company engaged in the dermatology business with a range of brands in the areas of aesthetics, wound care and skin care. Aesthetics provides dermatology solutions through ...
02/09/16 11:07 AMSinclair Pharma plc ( SPH ) - Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in. The currency of all prices and ...

Social

About Sinclair Pharma PLC

Sinclair Pharma PLC logoSinclair Pharma plc, formerly Sinclair IS Pharma plc, is a United Kingdom-based specialty pharmaceutical company. The Company is engaged in the manufacture and wholesale distribution of dermatological products. Its segments are Country Operations, which include its operations in France, the United Kingdom, Italy, Germany and Spain, and International Operations, under which the Company sells through a local distributor. The Company's product categories include Aesthetic Care, Skin Care, Wound Care and Non-Dermatology. The Company provides aesthetic dermatology solutions through thread lift, collagen stimulation and dermal fillers. The Company's aesthetic products include Silhouette Soft, Ellanse, Perfectha, Sculptra and USOFT Massage Gel. Its Silhouette Soft is inserted in the subcutaneous tissue. Its USOFT Massage Gel is a gel used for facial massage. It is engaged in research and development, and owns various product rights and licenses in a range of territories in which it trades.

Industry, Sector and Symbol:
  • Sector: N/A
  • Industry: N/A
  • Sub-Industry: N/A
  • Exchange: LON
  • Symbol: SPH
  • CUSIP:
Key Metrics:
  • Previous Close: $0.41
  • 50 Day Moving Average: $31.68
  • 200 Day Moving Average: $35.44
  • P/E Ratio: N/A
  • P/E Growth: -4.79
  • Market Cap: $152.82M
  • Current Year EPS Consensus Estimate: $-1.89 EPS
  • Next Year EPS Consensus Estimate: $N/A EPS
Additional Links: